Trellis Bioscience, Inc.

Amendment

CIK: 0001162015·Biotechnology·DELAWARE·Filed: Oct 29, 2026

Total Offering

Indefinite

Amount Sold

$9,093,000

Investors

16

First Sale

Jan 30, 2026

Offering Details

Type: Equity, Other: Series C Interests
Exemptions: Rule 506(b)
Entity Type: Corporation
Non-Accredited Investors: No

Related Persons

Name	Role
Nora Mende	Related Person
Larry Kauvar	Related Person

Company

Trellis Bioscience, Inc.

702 Marshall Street

Redwood City, CA, 94063

408-772-8049

SEC Filing

0000929638-26-004073

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.